Literature DB >> 11820454

Hyperalgesia and edema responses induced by rat peripheral blood mononuclear cells incubated with carrageenin.

M A De Resende1, W G Pimenta Dos Rei, L S Pereira, W Ferreira, M H Perez Garcia, M M Santoro, J Nogueira de Francischi.   

Abstract

The aim of this study was to verify the role played by mononuclear cells in an acute (nonimmune) inflammatory reaction. Mononuclear cells purified from rat peripheral blood were incubated for 1, 2, or 24 h with 100 or 250 microg/ml carrageenin (Cg). The resultant donor supernatant was injected into recipient rats to test its ability to induce hyperalgesia (reduction in threshold for paw pressure) and edema (increase in paw volume). Mononuclear cell supernatants (MnS) induced a significant time- and dose-dependent hyperalgesia and edema in rat paws, which reached a maximal effect at 3 h, lasted for 6 h, and returned to basal levels at 24 h of injection. Prostaglandins and cytokines (interleukin 1, 2, 6, 8, and tumor necrosis factor alpha) accounted for the hyperalgesia induced by MnS, as it was reduced (40 to 90%) by synthesis inhibitors such as indomethacin, dexamethasone, rolipram, and cyclosporin added to the cultures at a microgram dose-range. Edema was dependent on serotonin release in rat paws. These results indicate that mononuclear cells may be important contributors to acute inflammatory reactions, especially under those conditions where pain is an important component.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11820454     DOI: 10.1023/a:1012812124461

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

Authors:  M Di Rosa; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

Review 2.  Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy.

Authors:  J A Mitchell; T D Warner
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 3.  CC chemokines in allergic inflammation.

Authors:  M Baggiolini; C A Dahinden
Journal:  Immunol Today       Date:  1994-03

Review 4.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 5.  Interleukin-1.

Authors:  C A Dinarello
Journal:  Rev Infect Dis       Date:  1984 Jan-Feb

6.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Sensitization by dexamethasone of lymphocyte cyclic AMP formation: evidence for increased function of the adenylyl cyclase catalyst.

Authors:  M C Michel; J Knapp; H Ratjen
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

8.  Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor.

Authors:  J N Francischi; M F Dias; O A Rocha; M S de Abreu Castro; M A Kiyomi Funayama Tatsuo; P Farinelli; C M Pacheco; D L Ferreira-Alves; P Sirois
Journal:  Int Arch Allergy Immunol       Date:  1996-04       Impact factor: 2.749

9.  Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients.

Authors:  T D Batiuk; F Pazderka; P F Halloran
Journal:  Transplantation       Date:  1995-05-27       Impact factor: 4.939

10.  The origin and kinetics of mononuclear phagocytes.

Authors:  R van Furth; Z A Cohn
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

View more
  1 in total

1.  5-hydroxyindolacetic acid (5-HIAA), a main metabolite of serotonin, is responsible for complete Freund's adjuvant-induced thermal hyperalgesia in mice.

Authors:  Yong Chen; Florian Palm; Klaus-Peter Lesch; Manfred Gerlach; Rainald Moessner; Claudia Sommer
Journal:  Mol Pain       Date:  2011-03-30       Impact factor: 3.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.